The role of the tumor microbe microenvironment in the tumor immune microenvironment: bystander, activator, or inhibitor?
The role of the tumor microbe microenvironment in the tumor immune microenvironment: bystander, activator, or inhibitor?
复制标题
肿瘤微生物微环境在肿瘤免疫微环境中的作用:旁观者、激活剂还是抑制剂?
DOI:
10.1186/s13046-021-02128-w
复制
发表时间:
2021-10-16
期刊:
影响因子:
--
通讯作者:
Shen H
中科院分区:
文献类型:
--
作者:
Ma J;Huang L;Hu D;Zeng S;Han Y;Shen H
The efficacy of cancer immunotherapy largely depends on the tumor microenvironment, especially the tumor immune microenvironment. Emerging studies have claimed that microbes reside within tumor cells and immune cells, suggesting that these microbes can impact the state of the tumor immune microenvironment. For the first time, this review delineates the landscape of intra-tumoral microbes and their products, herein defined as the tumor microbe microenvironment. The role of the tumor microbe microenvironment in the tumor immune microenvironment is multifaceted: either as an immune activator, inhibitor, or bystander. The underlying mechanisms include: (I) the presentation of microbial antigens by cancer cells and immune cells, (II) microbial antigens mimicry shared with tumor antigens, (III) microbe-induced immunogenic cell death, (IV) microbial adjuvanticity mediated by pattern recognition receptors, (V) microbe-derived metabolites, and (VI) microbial stimulation of inhibitory checkpoints. The review further suggests the use of potential modulation strategies of the tumor microbe microenvironment to enhance the efficacy and reduce the adverse effects of checkpoint inhibitors. Lastly, the review highlights some critical questions awaiting to be answered in this field and provides possible solutions. Overall, the tumor microbe microenvironment modulates the tumor immune microenvironment, making it a potential target for improving immunotherapy. It is a novel field facing major challenges and deserves further exploration.
登录
查看更多内容
影响因子:
--
作者:
Booth L;Roberts JL;Poklepovic A;Kirkwood J;Dent P
通讯作者:
Dent P
DOI:
10.3322/caac.21398
发表时间:
2017-07-08
期刊:
CA: a cancer journal for clinicians
影响因子:
--
作者:
Bhatt AP;Redinbo MR;Bultman SJ
通讯作者:
Bultman SJ
影响因子:
11.5
作者:
Bonnet, Mathilde;Buc, Emmanuel;Darfeuille-Michaud, Arlette
通讯作者:
Darfeuille-Michaud, Arlette
影响因子:
82.9
作者:
Binnewies M;Roberts EW;Kersten K;Chan V;Fearon DF;Merad M;Coussens LM;Gabrilovich DI;Ostrand-Rosenberg S;Hedrick CC;Vonderheide RH;Pittet MJ;Jain RK;Zou W;Howcroft TK;Woodhouse EC;Weinberg RA;Krummel MF
通讯作者:
Krummel MF
影响因子:
1.6
作者:
Apostolou P;Tsantsaridou A;Papasotiriou I;Toloudi M;Chatziioannou M;Giamouzis G
通讯作者:
Giamouzis G